4.8 News Item

Abbott boosts investment in NRF2 activators for reducing oxidative stress

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pablo E. Pergola et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)